ArticleFrontiers in immunology2025

Short-course PD-1 blockade in locally advanced nasopharyngeal carcinoma: a phase II randomized trial protocol (Tori-013).

Hongyuan Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.